Longevity & AgingResearch PaperOpen Access

Werner syndrome case shows what accelerated aging looks like in a 35-year-old man

A homozygous WRN splice variant produced cataracts, diabetes, hypogonadism, osteopenia and non-healing ulcers by age 35 in one man. A single-patient report.

Thursday, November 19, 2026 0 views
Published in Clin Case Rep
clinician examining the hands of an elderly-looking young man with tight atrophic skin in a hospital clinic

Summary

This is a case report of a 35-year-old Bangladeshi man with Werner syndrome, a rare inherited progeroid disorder caused by loss of the WRN protein, a DNA helicase needed for DNA repair, replication and telomere upkeep. He stopped growing at 15 and developed cataracts in both eyes, early graying, tight scleroderma-like skin, muscle wasting, diabetes, low testosterone, thin bones, joint fusion at the ankle, and ulcers that would not heal. Genetic testing found a homozygous WRN splice-site variant. Treatment is supportive only. This is one patient, so it shows the clinical picture, not a treatment effect. His story shows how failure of genome maintenance can compress many age-related diseases into early adulthood.

Detailed Summary

Werner syndrome is called adult progeria because normal childhood development gives way to a cluster of age-related diseases in the 20s and 30s. The cause is loss of function of WRN, a RecQ-family DNA helicase involved in DNA replication, repair, recombination and telomere maintenance. Without it, telomeres erode faster and cells enter senescence early. For readers interested in aging, the syndrome is a human model of what happens when genome maintenance fails.

The authors describe one 35-year-old man from Bangladesh, a single-patient case report with no comparison group. His growth stopped at age 15. He had a BMI of 16.7 kg/m2, graying hair from about age 20, a hoarse high-pitched voice, bilateral posterior subcapsular cataracts, tight atrophic skin on the hands and feet, generalized muscle wasting, and ankylosis of the right ankle. He had a 3 x 3 cm necrotic heel ulcer and a 2 x 2 cm elbow ulcer, both recurrent. His parents were not consanguineous, but a younger sister has a similar appearance. She was not genetically tested.

Laboratory results showed normocytic normochromic anemia (hemoglobin 10.2 g/dL), ESR 63 mm/hr, triglycerides 386 mg/dL, and ferritin 2831 ng/mL. Gonadotropins were raised (FSH 16.5, LH 10.37 mIU/mL) while testosterone was 21 ng/dL, consistent with primary hypogonadism. He had a discordant puberty: testicular volumes of 10 to 12 mL with no pubic or axillary hair. X-rays showed marked generalized osteopenia with talocalcaneal and ankle ankylosis, and ECG showed left ventricular hypertrophy. Diabetes had been diagnosed 15 years earlier, yet HbA1c was 5.2% on metformin 850 mg daily.

Genetic testing through the International Registry of Werner Syndrome found a homozygous WRN variant, c.3233+2T>C in intron 26, classified as pathogenic and previously reported in another patient. Management was supportive only: metformin after gliclazide, antibiotics and dressings for ulcers, and conservative care for joints and bone. His TSH was suppressed at 0.005 μIU/mL on levothyroxine 150 μg/day, which suggests over-replacement, so the dose was cut to 100 μg/day. Free T4 was not available.

The discussion notes that osteoporosis (91%), hypogonadism (80%), diabetes (71%), neoplasms (43%) and atherosclerosis (40%) are common in Werner syndrome, and that deaths typically come from heart attacks and cancers such as thyroid carcinoma and sarcoma. Candidate therapies mentioned include vitamin C, rapamycin, farnesyltransferase inhibitors, metreleptin and stem cell approaches. None of these was tested in this patient, and no efficacy data come from this report.

Several caveats apply. The extreme hyperferritinemia was unexplained: the authors suggest inflammation but did not exclude liver disease or iron overload. The LVH on ECG and a diastolic murmur were not confirmed by echocardiography or vascular imaging, so established atherosclerosis cannot be claimed. The sister's diagnosis remains unconfirmed. Follow-up showed progression, and the prognosis is guarded.

Key Findings

  • Homozygous pathogenic WRN splice variant c.3233+2T>C (intron 26) confirmed the diagnosis in a single 35-year-old man
  • Growth arrested at 15; BMI 16.7 kg/m2 with bilateral posterior subcapsular cataracts and premature graying from about age 20
  • Primary hypogonadism: testosterone 21 ng/dL (reference 300-1000) with FSH 16.5 and LH 10.37 mIU/mL, and discordant puberty
  • Triglycerides 386 mg/dL, diabetes for 15 years (HbA1c 5.2% on metformin 850 mg/day), hemoglobin 10.2 g/dL
  • X-ray showed marked generalized osteopenia with ankle and talocalcaneal ankylosis; ECG showed LVH, unconfirmed by echocardiography
  • Ferritin of 2831 ng/mL with ESR 63 mm/hr was left unexplained, and no iron overload or liver workup was done
  • Recurrent heel and elbow ulcers responded only temporarily to antibiotics and dressings; follow-up showed progression, with no cure

Methodology

This is a single-patient case report with clinical examination, laboratory testing, imaging (ankle X-ray, ECG) and targeted WRN sequencing through the International Registry of Werner Syndrome. There was no control group and no statistical analysis. Written informed consent was obtained. Follow-up length was not reported. Evidence level is descriptive: it documents the phenotype and genotype, not mechanism or treatment effect.

Study Limitations

The report covers one patient, and the sister's suspected case was never genetically tested, so familial inheritance is unconfirmed. Cardiac findings lacked echocardiography or vascular imaging, free T4 was unavailable, and the cause of the hyperferritinemia was not established. The authors report no funding and no conflicts of interest.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.

Enter your email to subscribe: